Item 5e. Other matters arising from the international drug control treaties Chair: We will continue agenda item 5e to elect the second co-chair of the expert panel. I recall that there are two co-chairs selected, one by the CND and one Secretary General. It should be chosen with consideration to balanced representation and diverse policy …
United Kingdom of Great Britain and Northern Ireland
Plenary – Wednesday Afternoon Session
Item 6. Follow-up to the implementation at the national, regional, and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem (continued) Chair: I want you to hear updates from the Youth Forum, the WHO/INCB Scientific Network, the UNODC/CSO consultation on HIV AIDS, and …
Plenary — Wednesday afternoon session
Youth Forum: Your excellencies, distinguished delegates, ladies and gentleman. From 25 countries we gather as a unified voice to address the issue of substance use in our communities. This is not a new challenge and has been tackled over the past decades. Everyday there are new substances threatening individuals and society as a whole. It …
Plenary — Wednesday morning session
Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: First, Commission will consider recommendations of WHO on 4 substances, namely: (a) Whether or not it wishes to include N-pyrrolidino protonitazene in Schedule I of the 1961 Convention as amended; (b) Whether or not it …
Item 5. Implementation of the international drug control treaties (Monday morning)
Item 5b UNODC, Drugs, Laboratory and Scientific Services Branch (DLSSB): Thank you, Mr. Chair. distinguished delegates, ladies and gentlemen, as you’re well aware that new psychoactive substances are not under international control, but they produce the same harmful effects as the ones we have under control. In just over a decade, the number of these …
Item 3. High-level segment (Friday morning)
Canada: Esteemed Chair, Ministers, Heads of Delegation, Distinguished Delegates, and Civil Society Representatives: Canada is experiencing one of the most serious public health crises in our country’s history: an unrelenting toxic drug and overdose crisis. The impact and scope of the toxic drug crisis is devastating and more complex than ever. Tragically, we have seen …